Entering text into the input field will update the search result below

Basilea Pharmaceutica AG reports FY15 results

  • Basilea Pharmaceutica AG (OTC:BPMUF): FY15 EPS of -CHF6.09
  • Contract Revenue of CHF51.2M (+21.6% Y/Y)
  • Press Release

Recommended For You

More Trending News

About BPMUF Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
BPMUF--
Basilea Pharmaceutica AG